Objective: This work aims to define patient doses and factors which influence them for all critical groups of patients in routine mammography. Methods: A level of risks and benefits of screening mammography is under constant scrutiny. The size which best describes the amount of risk for glandular tissue caused by application of radiation in mammography is called mean glandular dose. One hundred and five patients from 40 to 78 years of age were included in this study from the Department of Radiology of the University Clinical Center Tuzla. Clinical data were collected from 400 mammograms taken from 105 women from routine mammographic screening. The exposure conditions of each mammogram were recorded. The mean glandular dose was calculated based on measuring ESAK, half value layer, kVp, mAs, breast thickness and clinical spectrum. Results: Mean MGD for women between 40 and 49 was 1.22 ± 0.47 mGy, for the group between 50 and 64 mean MGD was 1.24 ± 0.45 mGy and 1.23 ± 0.40 mGy for the group between 65 and 78. According to the correlation analysis, there was significant statistical significance between the MGD and a CBT (r = 0.709, p < 0.01). Conclusion: Values of MGD doses ranged within acceptable limits and were somewhat higher due to the extremely high value of compressed breast thickness.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.